<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C1563715" disease_type="Disease or Syndrome" abbrv="">Andersen-Tawil syndrome</z:e> (ATS) is characterized by hypo-normokaliemic muscle <z:hpo ids='HP_0003768'>periodic paralysis</z:hpo>, dysmorphic features and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Most cases are caused by mutations in KCNJ2, encoding for the <z:chebi fb="120" ids="26216">potassium</z:chebi> inwardly rectifying channel, Kir2.1 (ATS1) </plain></SENT>
<SENT sid="2" pm="."><plain>Although KCNJ2 mutations show no obvious genotype-phenotype correlations and <z:hpo ids='HP_0003829'>incomplete penetrance</z:hpo>, signs of cardiac involvement are usually present in most ATS1 cases </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, here we describe an Italian ATS1 patient, carrying a c.574Aâ†’G mutation in KCNJ2, who had both <z:hpo ids='HP_0001999'>facial dysmorphisms</z:hpo> and muscle <z:hpo ids='HP_0003768'>periodic paralysis</z:hpo> but who did not manifest any cardiac involvement, although the same mutation was originally described in a Japanese kindred, in which <z:hpo ids='HP_0000001'>all</z:hpo> affected individuals manifested a severe cardiac phenotype </plain></SENT>
</text></document>